Protonintel
4 known investors
Proton Intelligence develops CKM, a minimally invasive subcutaneous sensor for continuous potassium (K+) monitoring in patients across the cardiorenal care continuum, including heart failure and chronic kidney disease. The device is aimed at clinicians managing dyskalemia risk in acute, outpatient, and chronic settings.
Investors · 4
Frequently asked questions
- What does Protonintel do?
- Proton Intelligence develops CKM, a minimally invasive subcutaneous sensor for continuous potassium (K+) monitoring in patients across the cardiorenal care continuum, including heart failure and chronic kidney disease. The device is aimed at clinicians managing dyskalemia risk in acute, outpatient, and chronic settings.
- Who are Protonintel's investors?
- Protonintel's investors include ACADEMY INVESTOR, Beresford Ventures, SOSV, AIN Ventures.